Treatment of blood disease with chronic subdural hematoma
10.3969/j.issn.1001-6325.2018.07.019
- VernacularTitle:血液系统疾病患者合并慢性硬膜下血肿的治疗
- Author:
Xiao ZHANG
1
;
Hao WU
;
Bai-Tao MA
;
Jian-Bo CHANG
;
Yi-Hao CHEN
;
Wen-Bin MA
;
Yong-Ning LI
;
Ren-Zhi WANG
;
Jun-Ji WEI
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院 神经外科
- Keywords:
hematological illness;
chronic subdural hematoma;
surgical treatment;
effective rate;
mortality rate
- From:
Basic & Clinical Medicine
2018;38(7):999-1002
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the characteristics of patients with hematological illness and chronic subdural hematoma.,and the effect of blood disease on the treatment of chronic subdural hematoma. To guide the treatment of patients who both with hematological illness and chronic subdural hematoma. Methods Through a retrospective study of the cases of chronic subdural hematoma from January 1, 2000 to June 1, 2017 in Peking Union Medical College Hospital, the following items were investigated. 1).According to whether or not they were associated with blood disorders, the collected cases were divided into the blood disorders group and the non-blood disorders group. And the clinic data of the sex composition, average ages, treatment effect and mortality were compared. 2). Ac-cording to the treatment, the cases with blood disease were divided into the surgical group and the conservative group. And the treatment effect and mortality were compared. Results A total of 433 patients with chronic subdural hematoma were included in this study, including 35 patients associated with hematological illness. 1) Compared to the controls group, the patients group was younger( P＜0.01) ;the male ratio was lower ( P＜0.01) ; the treatment effect was lower( P＜0.001) and the mortality was higher( P＜0.001) . 2) Within the patients with hematological illness, the surgical group had the better treatment effect(78.9% vs 31.3%,P＜0.01) and the lower mortality (15.8% vs 50.0%,P＜0.05). Conclusions 1)The hematological illness group is younger and the male ratio is lower than the non-hematological illness group; 2) The hematological illness is a risk factor for the treatment of chronic subdural hematoma; 3) The patients who both with the hematological illness and the chronic subdural he-matoma should be treated by surgery.
